R.A. McNeil

R.A. McNeil is a private pharmaceutical company based in Chattanooga, Tennessee, specializing in the development and commercialization of mineral-based therapies for renal care. The company is best known for its MagneBind line of prescription phosphate binders, which are used to manage hyperphosphatemia in patients with chronic kidney disease and end-stage renal disease. These products utilize a specific combination of magnesium carbonate and calcium carbonate to effectively bind dietary phosphate in the gastrointestinal tract. By offering these formulations, R.A. McNeil provides a therapeutic alternative to traditional calcium-only or aluminum-based binders, aiming to reduce the risk of mineral imbalances. The company remains a dedicated provider of cost-effective solutions for the nephrology community and dialysis centers across the United States.